Surbhi Sarna's most recent trade in Penumbra Inc was a trade of 744 Common Stock done . Disclosure was reported to the exchange on Feb. 14, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Penumbra Inc | Surbhi Sarna | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Feb 2025 | 744 | 3,704 (0%) | 0% | 0 | Common Stock | |
| Penumbra Inc | Sarna Surbhi | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Feb 2024 | 665 | 2,960 (0%) | 0% | 0 | Common Stock | |
| Penumbra Inc | Sarna Surbhi | Director | Sale of securities on an exchange or to another person at price $ 247.68 per share. | 02 Jan 2024 | 85 | 2,295 (0%) | 0% | 247.7 | 21,053 | Common Stock |
| Penumbra Inc | Surbhi Sarna | Director | Sale of securities on an exchange or to another person at price $ 240.99 per share. | 02 Oct 2023 | 85 | 2,380 (0%) | 0% | 241.0 | 20,484 | Common Stock |
| Penumbra Inc | Surbhi Sarna | Director | Sale of securities on an exchange or to another person at price $ 266.62 per share. | 01 Sep 2023 | 85 | 2,465 (0%) | 0% | 266.6 | 22,663 | Common Stock |
| Penumbra Inc | Surbhi Sarna | Director | Sale of securities on an exchange or to another person at price $ 341.44 per share. | 03 Jul 2023 | 27 | 2,550 (0%) | 0% | 341.4 | 9,219 | Common Stock |
| Penumbra Inc | Surbhi Sarna | Director | Sale of securities on an exchange or to another person at price $ 276.36 per share. | 03 Apr 2023 | 28 | 2,577 (0%) | 0% | 276.4 | 7,738 | Common Stock |
| Penumbra Inc | Surbhi Sarna | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Feb 2023 | 680 | 2,605 (0%) | 0% | 0 | Common Stock | |
| Penumbra Inc | Surbhi Sarna | Director | Sale of securities on an exchange or to another person at price $ 227.11 per share. | 03 Jan 2023 | 27 | 1,925 (0%) | 0% | 227.1 | 6,132 | Common Stock |
| Biora Therapeutics Inc | Surbhi Sarna | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 03 Jan 2023 | 8 | 0 | - | - | Series X Preferred Stock | |
| Penumbra Inc | Surbhi Sarna | Director | Sale of securities on an exchange or to another person at price $ 191.21 per share. | 03 Oct 2022 | 28 | 1,952 (0%) | 0% | 191.2 | 5,354 | Common Stock |
| Biora Therapeutics Inc | Surbhi Sarna | Director | Sale of securities on an exchange or to another person at price $ 0.61 per share. | 05 Jul 2022 | 7,517 | 148,774 | - | 0.6 | 4,585 | Common Stock |
| Penumbra Inc | Surbhi Sarna | Director | Sale of securities on an exchange or to another person at price $ 124.41 per share. | 01 Jul 2022 | 27 | 1,980 (0%) | 0% | 124.4 | 3,359 | Common Stock |
| Biora Therapeutics Inc | Surbhi Sarna | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jun 2022 | 148,810 | 148,810 | - | - | Stock Option (Right to Buy) | |
| Biora Therapeutics Inc | Surbhi Sarna | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jun 2022 | 96,154 | 156,291 | - | 0 | Common Stock | |
| Penumbra Inc | Surbhi Sarna | Director | Sale of securities on an exchange or to another person at price $ 221.71 per share. | 01 Apr 2022 | 28 | 2,007 (0%) | 0% | 221.7 | 6,208 | Common Stock |
| Penumbra Inc | Surbhi Sarna | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Feb 2022 | 710 | 2,035 (0%) | 0% | 0 | Common Stock | |
| Penumbra Inc | Surbhi Sarna | Director | Sale of securities on an exchange or to another person at price $ 285.34 per share. | 03 Jan 2022 | 94 | 1,325 (0%) | 0% | 285.3 | 26,822 | Common Stock |
| Penumbra Inc | Surbhi Sarna | Director | Sale of securities on an exchange or to another person at price $ 278.06 per share. | 01 Nov 2021 | 907 | 1,419 (0%) | 0% | 278.1 | 252,200 | Common Stock |
| Biora Therapeutics Inc | Surbhi Sarna | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jul 2021 | 96,456 | 96,456 | - | - | Stock Option (Right to Buy) | |
| Biora Therapeutics Inc | Surbhi Sarna | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jul 2021 | 60,137 | 60,137 | - | 0 | Common Stock | |
| Penumbra Inc | Surbhi Sarna | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Feb 2021 | 535 | 2,326 (0%) | 0% | 0 | Common Stock |